Member Info for Crocqman

Brocal,
Fair point on this RNS originating from the Operator, but it IS UJO who will RNS about their own placings, nothing to do with the Operator on those, and both of those had a massive impact on the SP, taking months to recover in each case.
It does kind of suggest that even when the RNS comes from the Operator, it could well be within UJO/nomad/PR agency where any leak originates?
The Operator may be responsible for when an update RNS released is to be released, but each party will be responsible for issuing their own separate RNS, agreeing the content/wording to be released between them in advance, and we have seen in the past they although they are giving out the same information, they will be worded slightly differently, as you can clearly see today.
Not suggesting for a minute though, that DB is responsible himself, but can you say the same for SP Angel, or PR agency?

It's very poor for them to tag at the bottom of the article "Genedrive's shares have risen from a low of 9p before the pandemic to 43p – a bonanza for any investor", but conveniently fail to metion the highs seen during the pandemic.
Seems like a typical paid-for DM article/advert.
The type of factual comment you read from many on here, using a timeline that suits, but ignoring the real picture.
If GDR does fly, they will be claiming they tipped it a 9p in order to highlight how great they are.
Good to get a mention in a national though, as it may get new people looking to invest, but as always, dyor

Is it possible that one arm will be considered more of a Growth stock by the market, while the other may be considered more a Value stock?
Dividend expectations will likely be very different across the 2, regardless of their different sizes after the split, I suspect.
They also talk of disposals to help cover the cost of this action, so deals to be done.
Potentially interesting times here in 2021
gla

Maybe not, GP, but with the TR1 notificatin requirements, we can at least track their ownership, as with all of the other TR1 holders, and it will be pretty clear from this (albeit with a small time drag) whether they are buying, holding, or selling.
We cannot do this with any other holders, only speculate.

For me, if they only hold for SF, no problem, as I am doing the same with the majority, or all my holding.
Looking forward to a good week ahead
gla

Agree, very unlikely to be a 50-50 split

I take it as a good sign too, and make use of the filter quite quickly rather than indulge them (not always easy).
And don't forget, if you disagree with them, they are only posting to provide 'balance' to all the supposed endless positivity seen (who would have thought that from actual investors!), and because freedom of speech should be permitted on these boards regardless of whether you are invested, or not.

Yes, it makes me laugh when the manufacturers themselves use the latest gimmick to try and sell their newest model, using it as the main selling point, and then you see in the small print that it is only available on the higher spec models (i.e. not standard), and that you will also need a subscription, or additional compatable software to even use it.

A recent Ad for Vauxhall promoting their new small EV, boldy stated that petrol/diesel was dead, and EV was the future, conveniently forgeting, that the vast majority of their current available product is still diesel/petrol.

It is certainly good to have such a high percentage of shares in what is hopefully 'sticky hands', and there may be more yet to come from Forest.
Circa 25% of shares held by the 4 largest holders, much of it added in recent times too.
gla

I know it is the DM, so only to be expected, but a really poor article which, if anything, highlights the uphill struggle it will be for some media outlets to recognise 'real innovation' within car safety tech.
I mean, out of 5 innovations to look out for this year, 2 are for blind spot assistance!

https://www.thisismoney.co.uk/money/cars/article-9122065/The-five-safest-new-cars-buy-2021-named-experts.html

I am not sure anything is known on this, tbh.
I was just about to ask if anyone felt that GSK would use the final results to provide an update, or a firmer timeline/structure of this.
They suggested it would happen over the course of 2 years, although the focus was more likely to be in the 2nd year, and although we are nearly one year on, even the challenging situation of the past year should not have impacted too heavily on progressing this plan to a stage where a suitable plan would be known.
Hopeful we will hear something within the next month.

That's a good point about 'fair market share'
Quite often on these boards, and it occurs across every sector, a rival, or new competitor is always seen as being an either/or option, and bad news for potentially losing market share with the possibility of getting squezzed out always brought up.
It is not a case of one will succeed, and the other will not.
Yes, not everyone will thrive, but the reality is that the size of the market, and possibilities both locally, and globally and the sheer variety of uses/applications will be so big, that there will be space for multiple winners with the right product.
Multiple uses, and different options will suit different scenarios/requirements.
Competition will be healthy of course, but it is having the right product, the best possible product, manufactured either off the shelf, or bespoke, that is scaleable, and at a cost that is both affordable and that will generate sufficient profit to ensure growth, re-investment into the company, and building a brand name that can be recognised as a leader.
The groundwork is (or has already) being put in place across all the right areas, imo, and ExtremeE to showcase AFC will be a great advertisement. The right appointments seem to be getting made too.
2021 looks to be an exciting year for AFC, one to se if they really are up for the challenge.
A great time to be invested here, at what is really a big opportunity for considerable and rapid growth in this sector.
Good luck all, whatever your investment strategy here

Agusta/DerSack,
I am enjoying your posts swapping tips on good whiskies. Off-topic, but interesting nonetheless and no harm out of tradng hours, imo (some may disagree).
I have what I am told is a good 10 year old Macallan, but unfortunately, I have never been able to appreciate whisky, so it is reserved for visitors.

Fortunately though, the year of my birth happened to be a very good year for Port and also Bordeaux wine (amongst others), so I have always been able to toast 'big' birthdays with something decent that is also the same age as me!
I still have some nice bottles stored, and may open one or two at important SP milestones seen here.
Good health to you both

Looking forward to them 'turning the taps on'.
Post made especially for Alan. Long sigh

Too true, cperkin
May be worth switching off for a few days (commenting, anyway)
It is interesting though. that a few posters who disappeared here for a while (i,e, after the leaked placing), have suddenly returned at the same time bmd is promoting an imminent RNS, and are reminding everyone here how great everything is.
I won't be grabbing any more shares, but will certainly be watching closely here.
Fool me once, shame on you; fool me twice, shame on me. What is it for fooling me a 3rd time?
Good weekend all

The JUP SP was around the 390p level prior to the big 'covid' drop at the back end of February last year.
It has taken a very long time just to get back this close to the 300p level.

For circa 20 months, the SP was in a wide range of 300p to 400p, having dropped from highs of over 600p, almost exactly 3 years ago.
Not expecting to see a return that high any time soon, but with end of year results coming up at the end of Feb, I hope to see a continued rise over the coming weeks.
The dividend news will be particularly interesting, along with the AUM, fund flows, and an update on progress with the Merian funds following their addition

Not really relevant here, but I sold out of UKOG yesterday.
2 years of inactivity, false promises and nothing to get excited about for the future, plus big questionmarks over funding which I believe will be back to the so-called 'deat spiral' option as I cannot believe they will get yet another plaving away.
I took an 89% loss. My decision, and a poor investment choice on my behalf.

To think I was 95% down here though at one point, but with an exciting prospect at SF to at least get behind and see what came of it. Now at an average of 1.46 from a few additions due to the good news flow, over the past year clear direction on the main project, and the prospect of delivery on their SF aims. Funding the final key for me plus a possible new venture to catch the interest of new investors.
Depsite what many still continue to claim, ANGS, imo, will be in a very healthy position once the funding is in place, and with a good future ahead of them.
Comparing the SP to 2018 or earlier really is pointless, and not a like for like comparison as most will be aware. ANGS will rightly be valued on current fortunes and future acitivites.
Good luck to all investors here

haha,
While any timeline for action is up to you, and others have said they will give to the end of Jan, the interim results to 31/12 should be due around the first week of Feb.
They RNS'd the date for last year on 16 Jan.
Perhaps worth waiting to see what these show, and any possible trading update?

After finally selling out of a LT holding yesterday after 2 years of zero delivery on the promise of action on multiple fronts, and at least a further 6-9 months for anything likely to happen (at an 89% loss), GDR is now by far my worst performing stock currently.
I will be looking for these interim results, and a trading update before making any decision here, although most likely I will look to sell down half my holding, and keep the rest for the longer term future that I still see for the company.
Whatever you decide, good luck

What do you mean that an RNS will get this moving above placing and beyond?
The placing was completed more than 7 months ago, so really not sure how relevant the placing price is/was to what is going on here currently,

Penguins,
I think you should maybe avoid assuming what goes on around TR1's and notifications.
I'm pretty sure that large financial institutions like Cannacord and Barclays are aware of their own holdings (down to a single share), and the reporting requirements around thresholds.
When I say I'm pretty sure, I mean that I know they are sure what they hold and when to report.
I thought you were all about facts and not speculation?

Surely March (25th) would be more apt for an Aries update :-)